AzTrials
AzTrials

Spinal Cord InjuriesPAPAWNCT02244931

Comparison of Three Different Assisting Devices to Power Manual Wheelchairs in Patients With Spinal Cord Injury

A study testing Servomatic™ assisting device, E.Motion© assisting device and Standard manual Wheelchair in people with Spinal Cord Injuries, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to compare three assisting devices to propel personal wheelchairs (Servomatic A©, Servomatic B© and E.Motion©) to the standard personal manual wheelchair in patients with spinal cord injury. Read more about this study

Who is it for?
Ages 18 to 70 years
Conditions the study is for
Spinal Cord Injuries
What is being tested?
Servomatic™ assisting device, E.Motion© assisting device and Standard manual Wheelchair
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
106 participants
Where
1 siteFrance
Study dates
Sep 2011to Aug 2014
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Men and women aged between 18 and 70 years
  • Spinal cord injury C5-C8, paraplegic D1-D11, and D11 paraplegic below only for phases 1 and 2 phase 1 and 2
  • Spinal cord injury D1 and above only for phase 3
  • Having given free and informed consent
  • Negative pregnancy test for women of childbearing age

Who cannot join

  • No affiliation to a social security scheme
  • Refusal to participate in the clinical trial
  • Patient under guardianship
  • Major cognitive disorders
  • bedsores
  • Functional abnormality of the shoulder
Show all 10Show fewer
  • History of cardiovascular disease
  • ECG to suspect coronary insufficiency
  • Pregnant patients without effective treatment or contraceptive
  • Acute complication or systemic organ

Trial locations and contacts

1 site in 1 country.

France1 site
  • Physical Medicine and Rehabilitation, Raymond Poincaré Hospital

    Garches, 92380

Other trials in France

About this study

Official title: Comparison of Three Assisting Devices to Power Manual Wheelchairs in Patients With Spinal Cord Injury : Assessment of Biomechanical, Physiological and Functional Properties.

The purpose of this study is to compare three assisting devices to propel personal wheelchairs (Servomatic A©, Servomatic B© and E.Motion©) to the standard personal manual wheelchair in patients with spinal cord injury.

Read the detailed description

The objective of the study is to compare three assisting devices to propel personal wheelchairs (Servomatic A©, Servomatic B© and E.Motion©) to the standard personal manual wheelchair in patients with spinal cord injury.

The study consists of three distinct and independent phases:

  • Phase 1: Performance evaluation on wheelchair ergometer in order to compare the energy expenditure and kinetic characteristics in comparable situations with regard to speed and workload imposed to the wheelchair-patient couple.
  • Phase 2: Comparison of maneuverability and ease of crossing usual obstacles in outdoor and indoor paths with standardised obstacles. Trajectories are to be recorded in order to allow analysis by independent experts.
  • Phase 3: Comparison of the autonomy of patients afforded by the devices by comparing the patient's ability to transfer from wheelchair to car seat and from car seat to wheelchair, as well as ease of wheelchair packing in car, in the context of a standard city transport involving a car and the wheelchair.

The three phases are to be performed using the standard manual wheelchair and the three assisting devices in a randomized order.

Three different groups of patients are included in the three phases of the study.

Being tested
Servomatic™ assisting device, E.Motion© assisting device, Standard manual Wheelchair
Keywords
Spinal cord injuries, paraplegic, manual wheelchairs, assisting propelling device
Medical subject headings
Spinal Cord Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Servomatic™ assisting deviceDevice

    Servomatic™ is an hand controlled motorized device assisting to propel the wheelchair .

  • E.Motion© assisting deviceDevice

    E.Motion© is an hand controlled motorized device assisting to propel the wheelchair .

  • Standard manual WheelchairDevice

    Standard manual Wheelchair

Study groups in NCT02244931
Study groupRoleWhat they receive
Phase 1: Performance evaluation on ergometerExperimentalThe 3 devices are experimented in random order to compare them on performance using an ergometer wheelchair: * Servomatic™ assisting device * E.Motion© assisting device * Standard manual Wheelchair
Receives: Device: Servomatic™ assisting device; Device: E.Motion© assisting device; Device: Standard manual Wheelchair
Phase 2: Comparison of maneuverabilityExperimentalThe 3 devices are experimented in random order to compare them on maneuverability: * Servomatic™ assisting device * E.Motion© assisting device * Standard manual Wheelchair
Receives: Device: Servomatic™ assisting device; Device: E.Motion© assisting device; Device: Standard manual Wheelchair
Phase 3: Comparison of the autonomyExperimentalThe 3 devices are experimented in random order to compare them on the autonomy they afford to patients: * Servomatic™ assisting device * E.Motion© assisting device * Standard manual Wheelchair
Receives: Device: Servomatic™ assisting device; Device: E.Motion© assisting device; Device: Standard manual Wheelchair

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Phase 1: physiological parameters : Oxygen consumption.

    Measured: 3 hours

  2. Phase 2: Ease of crossing obstacles assessed by patients with a Visual Analog Scale

    Measured: 3 hours

  3. Phase 3: Time necessary to transfer from wheelchair to car and from car to wheelchair.

    Measured: 3 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Sep 2014 (estimated)
  2. Study startSep 2011
  3. Primary completionAug 2014
  4. Study completionAug 2014

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
106 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02244931
Sponsor's protocol ID
2011-A00151-40
Acronym
PAPAW
Status last verified
Sep 2013
First submitted
15 Sep 2014
Last updated
19 Sep 2014
Results posted
No
Data monitoring committee
No

Publications

  • Guillon B, Van-Hecke G, Iddir J, Pellegrini N, Beghoul N, Vaugier I, Figere M, Pradon D, Lofaso F. Evaluation of 3 pushrim-activated power-assisted wheelchairs in patients with spinal cord injury. Arch Phys Med Rehabil. 2015 May;96(5):894-904. doi: 10.1016/j.apmr.2015.01.009. Epub 2015 Jan 22.

    PubMed 25620717

Questions about this trial

What is this clinical trial studying?

A study testing Servomatic™ assisting device, E.Motion© assisting device and Standard manual Wheelchair in people with Spinal Cord Injuries, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Sep 2014. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Phase 1: physiological parameters : Oxygen consumption. (time frame: 3 hours). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02244931, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Sep 2014.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in